WCM
MLAB icon

Wealthcare Capital Management’s Mesa Laboratories MLAB Stock Holding History

Wealthcare Capital Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2
Closed – – 430
2021
Q1 		$0 Buy
+2
New +$550 ﹤0.01% 759

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Wealthcare Capital Management's MLAB Position: Q2 2021 in Review

Wealthcare Capital Management sold out of Mesa Laboratories (MLAB) in Q2 2021, closing a stake of 2 shares.

Wealthcare Capital Management first reported a position in MLAB in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2021.

  • Wealthcare Capital Management reported no remaining Mesa Laboratories position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Capital Management sold 2 Mesa Laboratories shares in Q2 2021.
  • Wealthcare Capital Management first reported a position in Mesa Laboratories in Q1 2021 and held it in 1 quarter.
  • Wealthcare Capital Management's Mesa Laboratories position peaked at $0 in Q1 2021.
  • 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2021.

Based on Wealthcare Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.